Literature DB >> 26440826

GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells.

Aijing Sun1,2, Changlin Li2, Ruibao Chen2, Yiling Huang2,3, Qi Chen4, Xiangjun Cui5, Huafeng Liu6, J Brantley Thrasher2, Benyi Li2,3,5,6.   

Abstract

BACKGROUND: Glycogen synthase kinase 3β (GSK3B, GSK-3β) is a multi-functional protein kinase involved in various cellular processes and its activity elevates after serum deprivation. We have shown that inhibition of GSK-3β activity triggered a profound autophagic response and subsequent necrotic cell death after serum deprivation in prostate cancer cells. In this study, we dissected the mechanisms involved in GSK-3β inhibition-triggered autophagy.
METHODS: Prostate cancer PC-3 and DU145 cells were used in the study. Multiple GSK-3β specific inhibitors were used including small chemicals TDZD8, Tideglusib, TWS119, and peptide L803-mts. Western blot assay coupled with phospho-specific antibodies were used in detecting signal pathway activation. ATP levels were assessed with ATPLite kit and HPLC methods. Autophagy response was determined by evaluating Microtubule-associated proteins 1A/1B light chain 3B (LC3B) processing and p62 protein stability in Western blot assays. Immunofluorescent microscopy was used to detect LKB1 translocation.
RESULTS: Inhibition of GSK-3β activity resulted in a significant decline of cellular ATP production, leading to a significant increase of AMP/ATP ratio, a strong trigger of AMP-activated protein kinase (AMPK) activation in prostate cancer PC-3 cells. In parallel with increased LC-3B biosynthesis and p62 protein reduction, the classical sign of autophagy induction, AMPK was activated after inhibition of GSK-3β activity. Further analysis revealed that Liver kinase B1 (LKB1) but not Calcium/calmodulin-dependent protein kinase kinase β (CaMKKβ) is involved in AMPK activation and autophagy induction triggered by GSK-3β inhibition. Meanwhile, GSK-3β inhibition promoted LKB1 translocation from nuclear to cytoplasmic compartment and enhanced LKB1 interaction with its regulatory partners Mouse protein-25 (MO25) and STE20-related adaptor (STRAD).
CONCLUSIONS: In conclusion, our data suggest that GSK-3β plays an important role in controlling autophagy induction by modulating the activation of LKB1-AMPK pathway after serum deprivation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  AMPK; GSK-3β; LKB1; autophagy; serum deprivation

Mesh:

Substances:

Year:  2015        PMID: 26440826      PMCID: PMC5408751          DOI: 10.1002/pros.23106

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  56 in total

Review 1.  Recent advances in vascular disrupting agents in cancer therapy.

Authors:  Elena Porcù; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

Review 3.  AMPK--sensing energy while talking to other signaling pathways.

Authors:  D Grahame Hardie
Journal:  Cell Metab       Date:  2014-10-30       Impact factor: 27.287

4.  Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.

Authors:  Yutaka Matsui; Hiromitsu Takagi; Xueping Qu; Maha Abdellatif; Hideyuki Sakoda; Tomoichiro Asano; Beth Levine; Junichi Sadoshima
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

5.  Lkb1 deficiency causes prostate neoplasia in the mouse.

Authors:  Helen B Pearson; Afshan McCarthy; Christopher M P Collins; Alan Ashworth; Alan R Clarke
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

6.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

7.  Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.

Authors:  L Kangas; M Grönroos; A L Nieminen
Journal:  Med Biol       Date:  1984

8.  Identification of phosphorylation sites in AMP-activated protein kinase (AMPK) for upstream AMPK kinases and study of their roles by site-directed mutagenesis.

Authors:  Angela Woods; Didier Vertommen; Dietbert Neumann; Roland Turk; Jayne Bayliss; Uwe Schlattner; Theo Wallimann; David Carling; Mark H Rider
Journal:  J Biol Chem       Date:  2003-05-21       Impact factor: 5.157

9.  Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein.

Authors:  Callum Parr; Raffaela Carzaniga; Steve M Gentleman; Fred Van Leuven; Jochen Walter; Magdalena Sastre
Journal:  Mol Cell Biol       Date:  2012-08-27       Impact factor: 4.272

Review 10.  The ULK1 complex: sensing nutrient signals for autophagy activation.

Authors:  Pui-Mun Wong; Cindy Puente; Ian G Ganley; Xuejun Jiang
Journal:  Autophagy       Date:  2013-01-07       Impact factor: 16.016

View more
  31 in total

1.  Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.

Authors:  Emiko Niiro; Sachiko Morioka; Kana Iwai; Yuki Yamada; Kenji Ogawa; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Biomed Rep       Date:  2018-01-17

2.  ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.

Authors:  Seung J Chung; Ganji Purnachandra Nagaraju; Arumugam Nagalingam; Nethaji Muniraj; Panjamurthy Kuppusamy; Alyssa Walker; Juhyung Woo; Balázs Győrffy; Ed Gabrielson; Neeraj K Saxena; Dipali Sharma
Journal:  Autophagy       Date:  2017-07-11       Impact factor: 16.016

3.  Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.

Authors:  Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-01-12       Impact factor: 6.048

4.  UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals.

Authors:  Jianhua Yu; Lawrence Shi; Xinggui Shen; Yunfeng Zhao
Journal:  Biochem Pharmacol       Date:  2019-05-11       Impact factor: 5.858

5.  Expression of autophagy related genes mTOR, Becline-1, LC3 and p62 in the peripheral blood mononuclear cells of systemic lupus erythematosus.

Authors:  Zhen-Zhen Wu; Jun-Jun Zhang; Cong-Cong Gao; Man Zhao; Sheng-Yun Liu; Guan-Min Gao; Zhao-Hui Zheng
Journal:  Am J Clin Exp Immunol       Date:  2017-01-15

6.  Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.

Authors:  Changlin Li; Chenchen He; Ying Xu; Haixia Xu; Yuzhe Tang; Hemantkumar Chavan; Shaofeng Duan; Antonio Artigues; Marcus Laird Forrest; Partha Krishnamurthy; Suxia Han; Jeffrey M Holzbeierlein; Benyi Li
Journal:  Prostate       Date:  2019-01-20       Impact factor: 4.104

7.  The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.

Authors:  Jolie Bou-Gharios; Sahar Assi; Hisham F Bahmad; Youssef Fares; Wassim Abou-Kheir; Hussein Kharroubi; Tarek Araji; Reda M Chalhoub; Farah Ballout; Hayat Harati
Journal:  Pharmacol Rep       Date:  2020-11-02       Impact factor: 3.024

8.  The Role of Alcohol-Induced Golgi Fragmentation for Androgen Receptor Signaling in Prostate Cancer.

Authors:  Sonia Manca; Cole P Frisbie; Chad A LaGrange; Carol A Casey; Jean-Jack M Riethoven; Armen Petrosyan
Journal:  Mol Cancer Res       Date:  2018-09-17       Impact factor: 5.852

9.  [Correlation of phosphorylated S6 protein expression in blood and brain tissue in mice and rats with kainic acid-induced seizure].

Authors:  Miao Fan; Shuminin Dong; Xinyi Zou; Boyuan Zheng; Yurun Huang; Jianda Wang; Linghui Zeng
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

10.  Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.

Authors:  Ramadevi Subramani; Elizabeth Gonzalez; Arunkumar Arumugam; Sushmita Nandy; Viviana Gonzalez; Joshua Medel; Fernando Camacho; Andrew Ortega; Sandrine Bonkoungou; Mahesh Narayan; Alok kumar Dwivedi; Rajkumar Lakshmanaswamy
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.